31 Mar 2021
Delfi Diagnostics Begins Enrollment for Prospective Lung Cancer Screening Trial ahead of Planned Commercial Test
Author: admintech | Filed under: Press ReleaseBALTIMORE, March 31, 2021 /PRNewswire/ — Delfi Diagnostics, Inc., a pioneering developer of next generation high performance, affordable liquid biopsy tests for early cancer detection, announced the start of enrollment for a nationwide prospective study and plans to commercialize an…